- Home
- EURK vs ANL Comparison
EURK vs ANL Comparison
Compare EURK & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EURK
- ANL
- Stock Information
- Founded
- EURK 2023
- ANL 2004
- Country
- EURK Hong Kong
- ANL Cayman Islands
- Employees
- EURK N/A
- ANL N/A
- Industry
- EURK
- ANL
- Sector
- EURK
- ANL
- Exchange
- EURK NYSE
- ANL Nasdaq
- Market Cap
- EURK 80.0M
- ANL 73.8M
- IPO Year
- EURK 2024
- ANL 2023
- Fundamental
- Price
- EURK $10.36
- ANL $1.47
- Analyst Decision
- EURK
- ANL Buy
- Analyst Count
- EURK 0
- ANL 2
- Target Price
- EURK N/A
- ANL N/A
- AVG Volume (30 Days)
- EURK 24.5K
- ANL 14.8K
- Earning Date
- EURK 01-01-0001
- ANL 08-08-2025
- Dividend Yield
- EURK N/A
- ANL N/A
- EPS Growth
- EURK N/A
- ANL N/A
- EPS
- EURK N/A
- ANL N/A
- Revenue
- EURK N/A
- ANL N/A
- Revenue This Year
- EURK N/A
- ANL N/A
- Revenue Next Year
- EURK N/A
- ANL N/A
- P/E Ratio
- EURK N/A
- ANL N/A
- Revenue Growth
- EURK N/A
- ANL N/A
- 52 Week Low
- EURK $10.03
- ANL $1.10
- 52 Week High
- EURK $10.53
- ANL $4.10
- Technical
- Relative Strength Index (RSI)
- EURK N/A
- ANL 37.32
- Support Level
- EURK N/A
- ANL $1.56
- Resistance Level
- EURK N/A
- ANL $1.74
- Average True Range (ATR)
- EURK 0.00
- ANL 0.15
- MACD
- EURK 0.00
- ANL -0.01
- Stochastic Oscillator
- EURK 0.00
- ANL 12.50
About EURK EUREKA ACQUISITION CORP
Eureka Acquisition Corp is a newly incorporated blank check company.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.